DEF 14C

DEF 14C Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: August 31, 2020
Period of Report: August 31, 2020
Accession Number: 0001493152-20-017009

View Document ↗ View on SEC.gov ↗